It is commonplace that medical drug development is a lengthy process. It is not only long, but in many cases a dead-end: researcher often have to abandon a previously promising development project before getting to the clinical research phase, i.e. going to testing on humans, because tests in later phase show weak results or prompts for side-effects.
As a first step of finding a medicine against a given disease, researchers experiment with various compounds or molecules. This lengthy and in many cases resultless job can be shortened dramatically with the help of artificial intelligence as can be read in this article.
All of us benefit from this: people suffering from a disease for which so far there has been no cure or curing is difficult have the chance for a drug which makes them healthy again or in fact life-saving. In addition, of course pharmaceutical companies may benefit from this use of AI as less efforts will turn into revenue-making products in a shorter time frame.
Last but not least let us mention that there is also a company in Hungary engaged in pharmaceutical drug development against cancer with the help of AI. This is Turbine.ai. We hope we can also share similar successful results about them in the near future.
Cover picture: Scientific Animations
